Shanghai Sundise Co.,Ltd. Release: Fuzheng Huayu Composition May Lead to Anti-Liver Fibrosis Treatment in U.S.

2011-11-08
BioSpace
SAN FRANCISCO--(BUSINESS WIRE)--At the annual Liver Meeting® of American Association for Study of Liver Diseases on Nov. 6, 2011, Professor Chenghai Liu, director of the Institute of Liver DiseasesLiver Diseases at Shanghai University of Traditional Chinese Medicine, revealed the botanical preparation Fuzheng Huayu (FZHY) and the newly identified compounds may help reverse liver fibrosis in hepatitis patients.
机构
适应症
靶点
-
药物
-
生物医药百科问答
全新生物医药AI Agent 覆盖科研全链路，让突破性发现快人一步
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。